Last €27.30 EUR
Change Today +0.23 / 0.85%
Volume 25.7K
As of 7:17 AM 04/23/14 All times are local (Market data is delayed by at least 15 minutes).

korian-medica (KORI) Snapshot

Open
€27.05
Previous Close
€27.07
Day High
€27.40
Day Low
€27.05
52 Week High
03/24/14 - €28.76
52 Week Low
04/25/13 - €15.71
Market Cap
2.1B
Average Volume 10 Days
96.1K
EPS TTM
€0.83
Shares Outstanding
78.4M
EX-Date
--
P/E TM
32.8x
Dividend
€0.60
Dividend Yield
2.20%
Current Stock Chart for KORIAN-MEDICA (KORI)

Related News

No related news articles were found.

korian-medica (KORI) Related Businessweek News

No Related Businessweek News Found

korian-medica (KORI) Details

Korian-Medica provides temporary and permanent dependency care services in Europe. As of March 26, 2013, it operated 327 facilities with a combined total of 34,797 beds. The company operated retirement homes, follow-up care and rehabilitation clinics, and psychiatric clinics, including 171 facilities with a total of 14,739 beds in France; 125 facilities with 15,709 beds in Germany; and 31 facilities with a total of 4,349 beds in Italy. Korian-Medica was founded in 2001 and is based in Paris, France.

40,000 Employees
Last Reported Date: 03/27/14
Founded in 2001

korian-medica (KORI) Top Compensated Officers

Chief Executive Officer and Managing Director
Total Annual Compensation: €491.1K
Managing Director of Operations and Member of...
Total Annual Compensation: €76.4K
Observer
Total Annual Compensation: €129.0K
Deputy Managing Director
Total Annual Compensation: €58.5K
Compensation as of Fiscal Year 2012.

korian-medica (KORI) Key Developments

Korian - Medica Recommends Dividend

At the next shareholders's meeting, Korian-Medica will recommend the payment of a dividend of 0.60 per share with an option to take the payment in shares.

Korian SA Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2013; Provides Earnings Guidance for the Year 2014

Korian SA announced audited consolidated earnings results for the year ended December 31, 2013. For the year, the company's revenues were EUR 1,371 million compared with EUR 1,108 million a year ago. EBITDAR was EUR 374 million compared with EUR 277 million a year ago. EBITDA was EUR 183 million compared with EUR 139 million a year ago. Operating income was EUR 100 million compared with EUR 87 million a year ago. Net income was EUR 29 million compared with EUR 23 million a year ago. Current net income was EUR 41 million compared with EUR 28 million a year ago. As on December 31, 2013, the company's net financial debt was EUR 716 million. EBIT was EUR 120.1 million compared with EUR 94.4 million a year ago. Income before taxes was EUR 55.6 million compared with EUR 52.7 million a year ago. Net income from continuing activities was EUR 31.4 million compared with EUR 25.9 million a year ago. Net cash flow from operating activities was EUR 119 million compared with EUR 126 million a year ago. Pro forma revenues were EUR 2,376 million compared with EUR 2,252 million a year ago. Pro forma EBITDAR was EUR 655 million compared with EUR 601 million a year ago. Pro forma EBITDA was EUR 335 million compared with EUR 300 million a year ago. Pro forma operating income was EUR 231 million compared with EUR 211 million a year ago. Pro forma net income was EUR 96 million compared with EUR 78 million a year ago. Pro forma current net income was EUR 97 million compared with EUR 78 million a year ago. Pro forma EBIT was EUR 232 million compared with EUR 212 million a year ago. Pro forma income before taxes was EUR 160 million compared with EUR 140 million a year ago. Pro forma net income from continuing activities was EUR 97 million compared with EUR 80 million a year ago. The group aims to achieve pro forma revenues of EUR 2.5 billion in 2014, and anticipates a slight increase in its operating profitability.

Korian SA(ENXTPA:KORI) added to CAC All-Tradable Index

Korian SA will be added to the CAC All-Tradable Index.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KORI:FP €27.30 EUR +0.23

KORI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Generale de Sante SA €14.60 EUR -0.15
Le Noble Age €16.95 EUR -0.04
Orpea €48.45 EUR +0.14
View Industry Companies
 

Industry Analysis

KORI

Industry Average

Valuation KORI Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 23.3x
TEV/Sales 0.9x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KORIAN-MEDICA, please visit www.groupe-korian.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.